m-fluconazole
multichem nz limited - fluconazole 100mg (polymorph form ii) - capsule - 100 mg - active: fluconazole 100mg (polymorph form ii) excipient: colloidal silicon dioxide gelatin iron oxide yellow lactose monohydrate magnesium stearate microcrystalline cellulose pregelatinised maize starch sodium laurilsulfate titanium dioxide - cryptococcosis, including cryptococcal meningitis and infections of other sites (e.g. pulmonary and cutaneous). normal hosts, and patients with aids, organ transplants or other causes of immunosuppression may be treated. fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal disease in patients with aids.
m-fluconazole
multichem nz limited - fluconazole 150mg (polymorph form ii) - capsule - 150 mg - active: fluconazole 150mg (polymorph form ii) excipient: colloidal silicon dioxide gelatin lactose monohydrate magnesium stearate microcrystalline cellulose pregelatinised maize starch quinoline yellow sodium laurilsulfate sunset yellow aluminium lake titanium dioxide - cryptococcosis, including cryptococcal meningitis and infections of other sites (e.g. pulmonary and cutaneous). normal hosts, and patients with aids, organ transplants or other causes of immunosuppression may be treated. fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal disease in patients with aids.
m-fluconazole
multichem nz limited - fluconazole 200mg (polymorph form ii) - capsule - 200 mg - active: fluconazole 200mg (polymorph form ii) excipient: colloidal silicon dioxide gelatin lactose monohydrate magnesium stearate microcrystalline cellulose pregelatinised maize starch sodium laurilsulfate titanium dioxide - cryptococcosis, including cryptococcal meningitis and infections of other sites (e.g. pulmonary and cutaneous). normal hosts, and patients with aids, organ transplants or other causes of immunosuppression may be treated. fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal disease in patients with aids.
m-fluconazole
multichem nz limited - fluconazole 50mg (polymorph form ii) - capsule - 50 mg - active: fluconazole 50mg (polymorph form ii) excipient: colloidal silicon dioxide gelatin iron oxide yellow lactose monohydrate magnesium stearate microcrystalline cellulose patent blue v pregelatinised maize starch quinoline yellow sodium laurilsulfate titanium dioxide - cryptococcosis, including cryptococcal meningitis and infections of other sites (e.g. pulmonary and cutaneous). normal hosts, and patients with aids, organ transplants or other causes of immunosuppression may be treated. fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal disease in patients with aids.
m-fluconazole
multichem nz limited - fluconazole 2 mg/ml (polymorph form ii) - solution for infusion - 2 mg/ml - active: fluconazole 2 mg/ml (polymorph form ii) excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - cryptococcosis, including cryptococcal meningitis and infections of other sites (e.g. pulmonary and cutaneous). normal hosts, and patients with aids, organ transplants or other causes of immunosuppression may be treated. fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal disease in patients with aids.
detrunorm xl 30mg capsules
mawdsley-brooks & company ltd - propiverine hydrochloride - modified-release capsule - 30mg
detrunorm xl 30mg capsules
de pharmaceuticals - propiverine hydrochloride - modified-release capsule - 30mg
cabazitaxel 10 mg/ml concentrate for solution for infusion
teva b.v. - cabazitaxel 2-propanol solvate - concentrate for solution for infusion - cabazitaxel
germisep sanitizer solution 75% vv
hovid berhad - 2-propanol -
detrunorm xl 30mg capsules
consilient health ltd - propiverine hydrochloride - modified-release capsule - 30mg